Evaluation of a Pilot Protocol for Detecting Infant Hyperopia

Ann M Morrison, Donald O Mutti1

  • 1The Ohio State University College of Optometry, Columbus, Ohio.

Insights

High hyperopia, a risk for vision problems, is common in infants. Tropicamide autorefraction effectively detects this condition during 2-month well-baby visits, enabling early intervention.

Area of Science:

  • Pediatric ophthalmology
  • Vision screening
  • Infant eye care

Background:

  • High hyperopia in children increases risks for strabismus, amblyopia, and literacy issues.
  • Early detection of high hyperopia is crucial for timely intervention.
  • Pediatric medical practices are ideal settings for infant vision screening.

Purpose of the Study:

  • To evaluate a pilot screening program for high hyperopia in 2-month-old infants.
  • To assess the effectiveness of tropicamide autorefraction in a pediatric setting.

Main Methods:

  • A pilot screening program was conducted in a pediatric medical practice.
  • Cycloplegic refractive error was measured using retinoscopy and autorefraction (Welch Allyn SureSight) with tropicamide in 473 infants.
  • Repeat cycloplegic retinoscopy with cyclopentolate was performed on infants with high hyperopia.

Main Results:

  • 5.9% of infants had high hyperopia (≥+5.00 D spherical equivalent) by retinoscopy.
  • 12.9% had high hyperopia (≥+5.00 D in at least one meridian) by retinoscopy with tropicamide.
  • Cycloplegic retinoscopy with cyclopentolate showed a statistically significant difference compared to tropicamide.

Conclusions:

  • High hyperopia is common in 2-month-old infants and detectable via cycloplegic autorefraction with tropicamide.
  • Enhanced collaboration between pediatric primary vision and medical care can improve infant vision screening.
  • Early detection through effective screening programs is vital for preventing vision impairments.
Abstract

Related Concept Videos